Harland Team Reveals Mechanism of Electric Field activated Spinal Cord Injury (SCI) Repair
Spinal cord injury (SCI) refers to damage to the spinal cord, a vital bundle of nerves that transmits signals between the brain and the rest of the body. The spinal cord extends from the lower part of the brain down the back, ending near the lower back. It plays a crucial role in controlling movement, sensation, and many bodily functions.
SCI can result from direct trauma to the spinal cord itself (like a severe blow or compression) or damage to the surrounding bones, tissues, and ligaments. This damage disrupts signal transmission, leading to changes in sensation, movement, strength, and bodily functions below the injury site. In some cases, these effects can be temporary, while in others, they may be permanent.
On June 26, 2025, Bruce Harland from the School of Pharmacy at the University of Auckland, New Zealand, published a study in Nature Communications titled: "Daily electric field treatment improves functional outcomes after thoracic contusion spinal cord injury in rats." This research reveals that daily electric field treatment improves functional recovery after thoracic spinal cord contusion injury in rats.
Products
Creative Biolabs provides an extensive portfolio of products and services designed to advance neuroscience investigations. Please contact us for more information.
Cat. No | Product Name | Product Types |
---|---|---|
NRZP-0323-ZP119 | NLRP3 Inflammasome Antibody Panel | Antibodies |
NRZP-0922-ZP3525 | Anti-NLRC4 Antibody (CBP14836) | Antibodies |
NRZP-0922-ZP1490 | Anti-AIM2 Antibody (CBP12801) | Antibodies |
NRYF-0625-XY227 | Gene Silencing siRNA Kit, Cdk9 | Gene Therapy Tools |
Services | Description |
---|---|
Spinal Cord Injury Disease Models | Accelerate the delivery of life-changing treatments for spinal cord injury (SCI) with our specialized disease models service. We de-risk your development pipeline through precisely controlled injury paradigms, comprehensive multi-modal assessment, expert study design, and advanced analytics. |
Overview
SCI can lead to permanent loss of sensory, motor, and autonomic functions, with very limited treatment options currently available. Recent research has highlighted the potential of low-frequency alternating electric fields in facilitating axon regeneration and promoting functional recovery. However, previously used metal electrodes are prone to corrosion, and their epidural placement restricts effective electric field penetration into the spinal cord.
In this study, the authors introduce an implantable thin-film device utilizing supercapacitor electrodes, which, when placed subdurally in rats, can safely and effectively deliver electric field therapy for thoracic spinal cord injury models. Compared to the control group, subdural electrical stimulation significantly improved hindlimb function and tactile sensitivity without inducing neuroinflammation within the spinal cord. While a noticeable increase in axon density near the injury site was not observed after a 12-week period, continuous in vivo monitoring of the electrodes and subsequent electrochemical analyses confirmed the sustained efficacy of the applied electric field throughout the study duration. These results indicate that electric field therapy, as a feasible treatment strategy, holds great promise for achieving long-term functional recovery following spinal cord injury.
Fig.1 Daily electric field therapy improves hindlimb motor function and tactile sensitivity after SCI.1
Findings of the Study
To sum up, electric field therapy significantly improved motor function in rats after SCI. This suggests that external electric fields likely promote the repair or regeneration of damaged neurons through some mechanism. Compared to surgery or other invasive treatments, electric field therapy is a relatively non-invasive method with higher safety and ease of use. This therapy is simple to implement, has fewer side effects, and is suitable for a wide range of patients.
Disclaimer: Please note that we do not provide the content above, nor do we hold copyright to it. This article is for informational and knowledge-sharing purposes only and does not constitute an offer of commercial services related to its subject matter.
Resources
Reference
- Harland, Bruce et al. "Daily electric field treatment improves functional outcomes after thoracic contusion spinal cord injury in rats." Nature communications vol. 16,1 5372. 26 Jun. 2025, doi:10.1038/s41467-025-60332-0. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)